Literature DB >> 24164668

Mechanism-based inhibition of HsaD: a C-C bond hydrolase essential for survival of Mycobacterium tuberculosis in macrophage.

Ali Ryan1, Sebastian Keany, Olga Eleftheriadou, Romain Ballet, Hung-Yuan Cheng, Edith Sim.   

Abstract

Mycobacterium tuberculosis remains the leading cause of death by a bacterial pathogen worldwide. Increasing prevalence of multidrug-resistant organisms means prioritizing identification of targets for antituberculars. 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase (HsaD), part of the cholesterol metabolism operon, is vital for survival within macrophage. The C-C bond hydrolase, HsaD, has a serine protease-like catalytic triad. We tested a range of serine protease and esterase inhibitors for their effects on HsaD activity. As well as providing a potential starting point for drug development, the data provides evidence for the mechanism of C-C bond hydrolysis. This screen also provides a route to initiate development of fragment-based inhibitors.
© 2013 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  HsaD; MCP hydrolase; Mycobacterium tuberculosis; cholesterol; inhibitors; mechanism

Mesh:

Substances:

Year:  2013        PMID: 24164668     DOI: 10.1111/1574-6968.12302

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  7 in total

1.  The unusual convergence of steroid catabolic pathways in Mycobacterium abscessus.

Authors:  Adam M Crowe; Jessica M C Krekhno; Kirstin L Brown; Jayesh A Kulkarni; Katherine C Yam; Lindsay D Eltis
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

2.  Gene expression profile analysis and target gene discovery of Mycobacterium tuberculosis biofilm.

Authors:  Fangxue Ma; Hong Zhou; Zhiqiang Yang; Chao Wang; Yanan An; Lihui Ni; Mingyuan Liu; Yang Wang; Lu Yu
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-14       Impact factor: 4.813

3.  Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach.

Authors:  Ali Ryan; Elena Polycarpou; Nathan A Lack; Dimitrios Evangelopoulos; Christian Sieg; Alice Halman; Sanjib Bhakta; Olga Eleftheriadou; Timothy D McHugh; Sebastian Keany; Edward D Lowe; Romain Ballet; Areej Abuhammad; William R Jacobs; Alessio Ciulli; Edith Sim
Journal:  Br J Pharmacol       Date:  2017-05-09       Impact factor: 8.739

Review 4.  Cholesterol metabolism: a potential therapeutic target in Mycobacteria.

Authors:  Areej Abuhammad
Journal:  Br J Pharmacol       Date:  2017-01-24       Impact factor: 8.739

5.  Phenotypic and genomic hallmarks of a novel, potentially pathogenic rapidly growing Mycobacterium species related to the Mycobacterium fortuitum complex.

Authors:  Reem Gharbi; Varun Khanna; Wafa Frigui; Besma Mhenni; Roland Brosch; Helmi Mardassi
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

6.  The Mycobacterium avium ssp. paratuberculosis specific mptD gene is required for maintenance of the metabolic homeostasis necessary for full virulence in mouse infections.

Authors:  Thorsten Meißner; Elke Eckelt; Tina Basler; Jochen Meens; Julia Heinzmann; Abdulhadi Suwandi; Walter M R Oelemann; Sandra Trenkamp; Otto Holst; Siegfried Weiss; Boyke Bunk; Cathrin Spröer; Gerald-F Gerlach; Ralph Goethe
Journal:  Front Cell Infect Microbiol       Date:  2014-08-14       Impact factor: 5.293

7.  Tackling tuberculosis: Insights from an international TB Summit in London.

Authors:  Arundhati Maitra; Cynthia A Danquah; Francesca Scotti; Tracey K Howard; Tengku K Kamil; Sanjib Bhakta
Journal:  Virulence       Date:  2015-07-07       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.